An improved rat model for chronic inflammatory bowel disease

[1] Mowat C(2011)Guidelines for the management of inflammatory bowel disease in adults Gut 60 571-607

[2] Cole A(2015)Experimental models of inflammatory bowel diseases Cell Mol Gastroenterol Hepatol 1 154-70

[3] Windsor A(2017)Dextran sodium sulfate colitis murine model: an indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis World J Gastroenterol 23 6016-29

[4] Ahmad T(2012)Dextran Sodium Sulphate Colitis Mouse Model: Traps and Tricks Journal of Biomedicine and Biotechnology 2012 1-13

[5] Arnott I(2014)Dextran sulfate sodium (DSS)-induced colitis in mice Curr Protoc Immunol 104 25-90

[6] Driscoll R(2018)New treatment options for inflammatory bowel diseases J Gastroenterol 53 585-107

[7] Kiesler P(2018)Nutraceuticals in rodent models as potential treatments for human inflammatory bowel disease Pharmacol Res 132 99-50

[8] Fuss IJ(2010)Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats World J Gastroenterol 16 3642-24

[9] Strober W(2011)High-carbohydrate, high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats J Cardiovasc Pharmacol 57 611-37

[10] Eichele DD(2014)Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1 channels Br J Pharmacol 171 4026-54

[1] Mowat C(2011)Guidelines for the management of inflammatory bowel disease in adults Gut 60 571-607

[2] Cole A(2015)Experimental models of inflammatory bowel diseases Cell Mol Gastroenterol Hepatol 1 154-70

[3] Windsor A(2017)Dextran sodium sulfate colitis murine model: an indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis World J Gastroenterol 23 6016-29

[4] Ahmad T(2012)Dextran Sodium Sulphate Colitis Mouse Model: Traps and Tricks Journal of Biomedicine and Biotechnology 2012 1-13

[5] Arnott I(2014)Dextran sulfate sodium (DSS)-induced colitis in mice Curr Protoc Immunol 104 25-90

[6] Driscoll R(2018)New treatment options for inflammatory bowel diseases J Gastroenterol 53 585-107

[7] Kiesler P(2018)Nutraceuticals in rodent models as potential treatments for human inflammatory bowel disease Pharmacol Res 132 99-50

[8] Fuss IJ(2010)Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats World J Gastroenterol 16 3642-24

[9] Strober W(2011)High-carbohydrate, high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats J Cardiovasc Pharmacol 57 611-37

[10] Eichele DD(2014)Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1 channels Br J Pharmacol 171 4026-54